Skripsi

Comparative cytotoxicity of five salicylic acid derivatives in human colorectal cancer cells of HT-29 = Studi Komparasi Sitotoksisitas Terhadap Lima Senyawa Derivat Asam Salisilat Terhadap Sel HT-29 Kanker Kolorektal.

Introduction: Colorectal cancer (CRC), the third most common cancer worldwide, has been a major problem throughout the world. Novel strategies are needed to prevent and cure it. As salicylic acid has been proven to have chemopreventive and cytotoxic effect towards colorectal cancer cells, we explore its derivatives effects on HT-29 cells. Methods: We use five salicylic acid derivatives, namely methyl salicylate, ethyl salicylate, butyl salicylate, isoamyl salicylate, and octyl salicylate. The success of the synthesis is observed through thin layer chromatography and by observing their physical and chemical properties. Then, we use MTT assay to obtain the five salicylic acid derivatives’ anticancer effect, which are presented through their percentage of inhibition and IC50 value. Results: Thin layer chromatography results indicate the success of compound synthesis, proven by the Rf values. All five salicylic acid derivatives exhibit inhibitory effects towards the growth of HT-29 colorectal cancer cells. The IC50 value obtained are as follows; methyl salicylate: 117,941 μg/mL, ethyl salicylate: 6,657 μg/mL, butyl salicylate: 58,851 μg/mL, isoamyl salicylate: 187,923 μg/mL, octyl salicylate: 116,545 Discussion: Ethyl salicylate is classified as an active anticancer compound, butyl salicylate is a moderately active compound. The rest are weakly active anticancer compounds. There is no correlation between compound length and anticancer activity, although there might be one with compound structure. To date, there are no known mechanism in which these derivatives are able to inhibit HT-29 colorectal cancer growth, however the most probable mechanism is through the COX pathway. Conclusion: Salicylic acid derivatives has anticancer effects towards HT-29 cells.
Key words: salicylic acid, alkylated salicylate, HT-29, colorectal cancer, anticancer


Latar Belakang: Kanker kolorektal, yang merupakan kanker ketiga tersering di dunia, telah menjadi persoalan di seluruh dunia. Dibutuhkan strategi baru untuk pencegahan dan penyembuhannya. Asam salisilat telah terbukti memiliki efek antikanker terhadap sel kanker kolorektal, sehingga mendorong penelitian lebih lanjut untuk mengetahui efek senyawa turunan asam salisilat terhadap pertumbuhan sel HT-29. Metode: Senyawa turunan asam salisilat yang digunakan dalam penelitian ini merupakan metil salisilat, etil salisilat, butil salisilat, isoamil salisilat, dan oktil salisilat. Pertama penulis akan melakukan kromatografi lapis tipis serta dengan mengobservasi sifat fisika dan kimia (formula, titik leleh, massa molekul, solubilitas, warna, dan aroma) dari senyawa-senyawa tersebut.. Lalu, analisa dari sifat antikanker kelima senyawa tersebut dilakukan menggunakan uji MTT, aktivitas antikanker dinyatakan dengan persentasi inhibisi dan nilai IC50. Hasil: Kromatografi lapis tipis menunjukkan kesuksesan dari sintesis senyawa, dengan nilai Rf yang sesuai. Kelima senyawa turunan asam salisilat menunjukkan efek penghambatan terhadap pertumbuhan sel HT-29. Nilai IC50 yang didapatkan adalah sebagai berikut; metil salisilat: 117,941 μg/mL, etil salisilat: 6,657 μg/mL, butil salisilat: 58,851 μg/mL, isoamil salisilat: 187,923 μg/mL, oktil salisilat: 116,545. Diskusi: Etil salisilat merupakan senyawa antikanker aktif, sedangkan butil salisilat tergolong cukup aktif. Tiga senyawa lainnya tergolong antikanker lemah. Tidak ada korelasi antara panjang senyawa dan aktivitas antikanker, walaupun kemungkinan adanya korelasi dengan struktur senyawa. Kesimpulan: Senyawa turunan asam salisilat memiliki efek antikanker terhadap sel HT29.
Kata Kunci: asam salisilat, turunan, HT-29, kanker kolorektal, antikanker